PHC Holdings Corporation
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and hi… Read more
PHC Holdings Corporation (PHCCF) - Net Assets
Latest net assets as of September 2025: $146.04 Billion USD
Based on the latest financial reports, PHC Holdings Corporation (PHCCF) has net assets worth $146.04 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($525.82 Billion) and total liabilities ($379.78 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $146.04 Billion |
| % of Total Assets | 27.77% |
| Annual Growth Rate | 14.97% |
| 5-Year Change | 31.25% |
| 10-Year Change | N/A |
| Growth Volatility | 20.66 |
PHC Holdings Corporation - Net Assets Trend (2020–2025)
This chart illustrates how PHC Holdings Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PHC Holdings Corporation (2020–2025)
The table below shows the annual net assets of PHC Holdings Corporation from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $141.17 Billion | +1.44% |
| 2024-03-31 | $139.16 Billion | +0.24% |
| 2023-03-31 | $138.83 Billion | +2.03% |
| 2022-03-31 | $136.06 Billion | +26.50% |
| 2021-03-31 | $107.56 Billion | +53.01% |
| 2020-03-31 | $70.30 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to PHC Holdings Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 82.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $2.99 Billion | 2.11% |
| Other Components | $138.65 Billion | 97.89% |
| Total Equity | $141.64 Billion | 100.00% |
PHC Holdings Corporation Competitors by Market Cap
The table below lists competitors of PHC Holdings Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Korea Electronic Power Industrial Development Co Ltd
KO:130660
|
$182.42 Million |
|
Blue Foundry Bancorp
NASDAQ:BLFY
|
$182.43 Million |
|
MEDICAL FACILITIES NEW
F:31F
|
$182.44 Million |
|
CapMan Oyj B
HE:CAPMAN
|
$182.47 Million |
|
Hampidjan hf
IC:HAMP
|
$182.38 Million |
|
Vicore Pharma Holding AB (publ)
ST:VICO
|
$182.21 Million |
|
Seche Environnem.
PA:SCHP
|
$182.20 Million |
|
InnovAge Holding Corp
NASDAQ:INNV
|
$182.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PHC Holdings Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 139,515,000,000 to 141,639,000,000, a change of 2,124,000,000 (1.5%).
- Net income of 10,484,000,000 contributed positively to equity growth.
- Dividend payments of 4,916,000,000 reduced retained earnings.
- New share issuances of 46,000,000 increased equity.
- Other factors decreased equity by 3,490,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $10.48 Billion | +7.4% |
| Dividends Paid | $4.92 Billion | -3.47% |
| Share Issuances | $46.00 Million | +0.03% |
| Other Changes | $-3.49 Billion | -2.46% |
| Total Change | $- | 1.52% |
Book Value vs Market Value Analysis
This analysis compares PHC Holdings Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-03-31 | $572.44 | $6.28 | x |
| 2021-03-31 | $871.74 | $6.28 | x |
| 2022-03-31 | $1092.32 | $6.28 | x |
| 2023-03-31 | $1101.33 | $6.28 | x |
| 2024-03-31 | $1106.98 | $6.28 | x |
| 2025-03-31 | $1122.35 | $6.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PHC Holdings Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.40%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 2.90%
- • Asset Turnover: 0.68x
- • Equity Multiplier: 3.76x
- Recent ROE (7.40%) is above the historical average (2.15%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 7.51% | 1.94% | 0.51x | 7.54x | $-1.75 Billion |
| 2021 | 15.80% | 5.52% | 0.54x | 5.32x | $6.20 Billion |
| 2022 | -6.25% | -2.48% | 0.58x | 4.37x | $-22.00 Billion |
| 2023 | -2.33% | -0.90% | 0.63x | 4.07x | $-17.02 Billion |
| 2024 | -9.24% | -3.64% | 0.63x | 4.04x | $-26.84 Billion |
| 2025 | 7.40% | 2.90% | 0.68x | 3.76x | $-3.68 Billion |
Industry Comparison
This section compares PHC Holdings Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PHC Holdings Corporation (PHCCF) | $146.04 Billion | 7.51% | 2.60x | $182.38 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |